Forge Biologics, Author at Forge Biologics

Forge Biologics Announces Positive FBX-101 Clinical Trial Update in Patients with Krabbe Disease Identified by Newborn Screening Ahead of RUSP Vote

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics Announces Positive FBX-101 Clinical Trial Update in Patients with Krabbe Disease Identified by Newborn Screening Ahead of RUSP Vote

Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental Understanding of AAV Production

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental Understanding of AAV Production

Ajinomoto agreed to buy Forge Biologics, a Columbus, Ohio-based contract development and manufacturing group focused on gene therapy

Manufacturing gene therapies for life Forge is a gene therapy development engine, enabling access to life-changing discoveries by bringing them […]

Read More… from Ajinomoto agreed to buy Forge Biologics, a Columbus, Ohio-based contract development and manufacturing group focused on gene therapy